Over the course of the projected period, the legionnaire disease testing market is anticipated to increase at a 9% CAGR, from US$ 292 million in 2022 to US$ 819.5 million by 2032. A serious type of pneumonia infection that inflames the lungs is called legionnaire’s disease. The bacteria legionella is the cause of legionnaire’s disease. …